The DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
PBPK models for the prediction of in vivo performance of oral dosage forms
Abstract
Drug absorption from the gastrointestinal (GI) tract is a highly complex process dependent upon numerous factors including the physicochemical properties of the drug, characteristics of the formulation and interplay with the underlying physiological properties of the GI tract. The ability to accurately predict oral drug absorption during drug product development is becoming more relevant given the current challenges facing the pharmaceutical industry. Physiologically-based pharmacokinetic (PBPK) modeling provides an approach that enables the plasma concentration-time profiles to be predicted from preclinical in vitro and in vivo data and can thus provide a valuable resource to support decisions at various stages of the drug development process. Whilst there have been quite a few successes with PBPK models identifying key issues in the development of new drugs in vivo, there are still many aspects that need to be addressed in order to maximize the utility of the PBPK models to predict drug absorption, including improving our understanding of conditions in the lower small intestine and colon, taking the influence of disease on GI physiology into account and further exploring the reasons behind population variability. Importantly, there is also a need to create more appropriate in vitro models for testing dosage form performance and to streamline data input from these into the PBPK models. As part of the Oral Biopharmaceutical Tools (OrBiTo) project, this review provides a summary of the current status of PBPK models available. The current challenges in PBPK set-ups for oral drug absorption including the composition of GI luminal contents, transit and hydrodynamics, permeability and intestinal wall metabolism are discussed in detail. Further, the challenges regarding the appropriate integration of results from in vitro models, such as consideration of appropriate integration/estimation of solubility and the complexity of the in vitro release and precipitation data, are also highlighted as important steps to advancing the application of PBPK models in drug development. It is expected that the "innovative" integration of in vitro data from more appropriate in vitro models and the enhancement of the GI physiology component of PBPK models, arising from the OrBiTo project, will lead to a significant enhancement in the ability of PBPK models to successfully predict oral drug absorption and advance their role in preclinical and clinical development, as well as for regulatory applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipids and Lipid-Based Formulations: Optimizing the Oral Delivery of Lipophilic Drugs
Porter, C. J. H., Trevaskis, N. L., & Charman, W. N. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2197 · Cited by 1,824
Valentin, J. (2002) · Annals of the ICRP · doi:10.1016/s0146-6453(03)00002-2 · Cited by 1,754
Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control
Yu, L. X. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9511-1 · Cited by 1,191
Rodgers, T., & Rowland, M. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20502 · Cited by 946
Intestinal permeability: an overview
Bjarnason, I., Macpherson, A., & Hollander, D. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90708-4 · Cited by 927
THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
Paine, M. F., Hart, H. L., Ludington, S. S., Haining, R. L., Rettie, A. E., & Zeldin, D. C. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008672 · Cited by 870
Transit of pharmaceutical dosage forms through the small intestine.
Davis, S. S., Hardy, J. G., & Fara, J. W. (1986) · Gut · doi:10.1136/gut.27.8.886 · Cited by 853
Paine, M. F., Khalighi, M., Fisher, J. M., Shen, D. D., Kunze, K. L., Marsh, C. L., Perkins, J. D., & Thummel, K. E. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37149-6 · Cited by 789
Rodgers, T., Leahy, D., & Rowland, M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20322 · Cited by 776 · cited 4×
“The fractions of lipid, protein, and water in each organ and sub-compartment are embedded in the software, enabling the calculation of tissue–plasma-partition coefficients using five different approaches (PK-Sim standard (PK-Sim , 2012), Rodgers and Rowland (Rodgers et al., 2005a,b; Rodgers and Rowland, 2006, 2007), S…”
MethodInfluentialUpper Gastrointestinal (GI) pH in Young, Healthy Men and Women
Dressman, J. B., Berardi, R. R., Dermentzoglou, L. C., Russell, T. L., Schmaltz, S. P., Barnett, J. L., & Jarvenpaa, K. M. (1990) · Pharmaceutical Research · doi:10.1023/a:1015827908309 · Cited by 775
Self-citationDissolution Media Simulating Conditions in the Proximal Human Gastrointestinal Tract: An Update
Jantratid, E., Janssen, N., Reppas, C., & Dressman, J. B. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9569-4 · Cited by 764
Self-citationNUGENT, S. G., KUMAR, D., RAMPTON, D. S., & EVANS, D. F. (2001) · Gut · doi:10.1136/gut.48.4.571 · Cited by 700
Enhancing intestinal drug solubilisation using lipid-based delivery systems
Porter, C. J. H., Pouton, C. W., Cuine, J. F., & Charman, W. N. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.014 · Cited by 690
Basic anatomical and physiological data for use in radiological protection : reference values
Valentin, J. (2002) · Medical Entomology and Zoology · Cited by 680
Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
Rowland, M., Peck, C., & Tucker, G. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100540 · Cited by 662
Rational Use of in Vitro P-glycoprotein Assays in Drug Discovery
Polli, J. W., Wring, S. A., Humphreys, J. E., Huang, L., Morgan, J. B., Webster, L. O., & Serabjit-Singh, C. S. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29270-3 · Cited by 662
Kalantzi, L., Goumas, K., Kalioras, V., Abrahamsson, B., Dressman, J. B., & Reppas, C. (2006) · Pharmaceutical Research · doi:10.1007/s11095-005-8476-1 · Cited by 658
Self-citationPredicting the Impact of Physiological and Biochemical Processes on Oral Drug Bioavailability
Agoram, B., Woltosz, W. S., & Bolger, M. B. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00179-x · Cited by 651
Self-citationThe gastrointestinal microbiota as a site for the biotransformation of drugs
Sousa, T., Paterson, R., Moore, V., Carlsson, A., Abrahamsson, B., & Basit, A. W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.009 · Cited by 618
Thummel, K. E., O'Shea, D., Paine, M. F., Shen, D. D., Kunze, K. L., Perkins, J. D., & Wilkinson, G. R. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90177-0 · Cited by 617
Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging
SCHILLER, C., FRÖHLICH, C. ‐., GIESSMANN, T., SIEGMUND, W., MÖNNIKES, H., HOSTEN, N., & WEITSCHIES, W. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02683.x · Cited by 596
Self-citationHilgendorf, C., Ahlin, G., Seithel, A., Artursson, P., Ungell, A.-L., & Karlsson, J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.014902 · Cited by 583
In vitro–in vivo correlations for lipophilic, poorly water-soluble drugs
Dressman, J. B., & Reppas, C. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00181-0 · Cited by 579
Self-citationPoulin, P., & Theil, F. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10005 · Cited by 568
de Waziers, I., Cugnenc, P. H., Yang, C. S., Leroux, J. P., & Beaune, P. H. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12474-9 · Cited by 502
van Zijl, P. C. M., Eleff, S. M., Ulatowski, J. A., Oja, J. M. E., Uluǧ, A. M., Traystman, R. J., & Kauppinen, R. A. (1998) · Nature Medicine · doi:10.1038/nm0298-159 · Cited by 501
Physiological Parameters for Oral Delivery and in Vitro Testing
Mudie, D. M., Amidon, G. L., & Amidon, G. E. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100149j · Cited by 490
Bischoff, K. B., Dedrick, R. L., Zaharko, D. S., & Longstreth, J. A. (1971) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600600803 · Cited by 480
Anatomy of body water and electrolytes
Edelman, I. S., & Leibman, J. (1959) · The American Journal of Medicine · doi:10.1016/0002-9343(59)90346-8 · Cited by 468
Barter, Z., Bayliss, M., Beaune, P., Boobis, A., Carlile, D., Edwards, R., Brian Houston, J., Lake, B., Lipscomb, J., Pelkonen, O., et al. (2007) · Current Drug Metabolism · doi:10.2174/138920007779315053 · Cited by 459 · cited 2×
“These are generally based on limited datasets in contrast to liver (Barter et al., 2007) and from samples prepared by mucosal scraping, which can bias the estimate for reasons stated above (Cubitt et al., 2009, 2011; Paine et al., 2006).”
BackgroundSelf-citationA compartmental absorption and transit model for estimating oral drug absorption
Yu, L. X., & Amidon, G. L. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00147-7 · Cited by 455
Winiwarter, S., Bonham, N. M., Ax, F., Hallberg, A., Lennernäs, H., & Karlén, A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9810102 · Cited by 453
Population-Based Mechanistic Prediction of Oral Drug Absorption
Jamei, M., Turner, D., Yang, J., Neuhoff, S., Polak, S., Rostami-Hodjegan, A., & Tucker, G. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9099-y · Cited by 452
Self-citationSun, D., Lennernas, H., Welage, L. S., Barnett, J. L., Landowski, C. P., Foster, D., Fleisher, D., Lee, K.-D., & Amidon, G. L. (2002) · Pharmaceutical Research · doi:10.1023/a:1020483911355 · Cited by 447
Ohtsuki, S., Schaefer, O., Kawakami, H., Inoue, T., Liehner, S., Saito, A., Ishiguro, N., Kishimoto, W., Ludwig-Schwellinger, E., Ebner, T., et al. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.042259 · Cited by 434
Gut instincts: Explorations in intestinal physiology and drug delivery
McConnell, E. L., Fadda, H. M., & Basit, A. W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.05.012 · Cited by 431
Poulin, P., & Theil, F. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200001)89:1<16::aid-jps3>3.0.co;2-e · Cited by 424
Mechanistic Approaches to Volume of Distribution Predictions: Understanding the Processes
Rodgers, T., & Rowland, M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9210-3 · Cited by 420
Characterization of Fluids from the Stomach and Proximal Jejunum in Men and Women
Lindahl, A., Ungell, A.-L., Knutson, L., & Lennernäs, H. (1997) · Pharmaceutical Research · doi:10.1023/a:1012107801889 · Cited by 408
Cyclic motor activity; migrating motor complex: 1985
Sarna, S. K. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90589-x · Cited by 383
In vitro models for the prediction of in vivo performance of oral dosage forms
Kostewicz, E. S., Abrahamsson, B., Brewster, M., Brouwers, J., Butler, J., Carlert, S., Dickinson, P. A., Dressman, J., Holm, R., Klein, S., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.08.024 · Cited by 373
Self-citationJamei, M., Dickinson, G. L., & Rostami-Hodjegan, A. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.53 · Cited by 368
Self-citationUpper Gastrointestinal pH in Seventy-Nine Healthy, Elderly, North American Men and Women
Russell, T. L., Berardi, R. R., Barnett, J. L., Dermentzoglou, L. C., Jarvenpaa, K. M., Schmaltz, S. P., & Dressman, J. B. (1993) · Pharmaceutical Research · doi:10.1023/a:1018970323716 · Cited by 367
Self-citationPrediction of Intestinal First-Pass Drug Metabolism
Yang, J., Jamei, M., Yeo, K., Tucker, G., & Rostami-Hodjegan, A. (2007) · Current Drug Metabolism · doi:10.2174/138920007782109733 · Cited by 366
Self-citationRiches, Z., Stanley, E. L., Bloomer, J. C., & Coughtrie, M. W. H. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028399 · Cited by 365
General approach for the calculation of tissue to plasma partition coefficients
Schmitt, W. (2008) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.09.010 · Cited by 349 · cited 2×
“The fractions of lipid, protein, and water in each organ and sub-compartment are embedded in the software, enabling the calculation of tissue–plasma-partition coefficients using five different approaches (PK-Sim standard (PK-Sim , 2012), Rodgers and Rowland (Rodgers et al., 2005a,b; Rodgers and Rowland, 2006, 2007), S…”
MethodCharacterization of Human Small Intestinal Cytochromes P-450
Zhang, Q.-Y., Dunbar, D., Ostrowska, A., Zeisloft, S., Yang, J., & Kaminsky, L. S. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15229-4 · Cited by 343
Budha, N. R., Frymoyer, A., Smelick, G. S., Jin, J. Y., Yago, M. R., Dresser, M. J., Holden, S. N., Benet, L. Z., & Ware, J. A. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.73 · Cited by 338
Yu, L. X., Lipka, E., Crison, J. R., & Amidon, G. L. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(96)00009-9 · Cited by 335
Rostami-Hodjegan, A. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.65 · Cited by 331
Self-citationVarma, M. V. S., Obach, R. S., Rotter, C., Miller, H. R., Chang, G., Steyn, S. J., El-Kattan, A., & Troutman, M. D. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901371v · Cited by 331
Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine
Kostewicz, E. S., Wunderlich, M., Brauns, U., Becker, R., Bock, T., & Dressman, J. B. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022511 · Cited by 318
Self-citationIntestinal permeability and its relevance for absorption and elimination
Lennernäs, H. (2007) · Xenobiotica · doi:10.1080/00498250701704819 · Cited by 304
Estimation of the increase in solubility of drugs as a function of bile salt concentration
Mithani, S. D., Bakatselou, V., TenHoor, C. N., & Dressman, J. B. (1996) · Pharmaceutical Research · doi:10.1023/a:1016062224568 · Cited by 303
Self-citationPoulin, P., & Theil, F.-P. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10128 · Cited by 303
Solubility of sparingly-soluble ionizable drugs
Avdeef, A. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.008 · Cited by 299
Gertz, M., Harrison, A., Houston, J. B., & Galetin, A. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.032649 · Cited by 297
Self-citationBerezhkovskiy, L. M. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20073 · Cited by 296
Takano, R., Sugano, K., Higashida, A., Hayashi, Y., Machida, M., Aso, Y., & Yamashita, S. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0162-4 · Cited by 281
P-Glycoprotein Increases from Proximal to Distal Regions of Human Small Intestine
Mouly, S., & Paine, M. F. (2003) · Pharmaceutical Research · doi:10.1023/a:1026183200740 · Cited by 276
Persson, E. M., Gustafsson, A.-S., Carlsson, A. S., Nilsson, R. G., Knutson, L., Forsell, P., Hanisch, G., Lennernäs, H., & Abrahamsson, B. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8192-x · Cited by 266
Avdeef, A., Berger, C. M., & Brownell, C. (2000) · Pharmaceutical Research · doi:10.1023/a:1007526826979 · Cited by 260
Teorell, T. (1937) · Archives internationales de pharmacodynamie et de thérapie · Cited by 260
Cyclic motor activity, migrating motor complex
Sarna, S. (1985) · Gastroenterology · Cited by 260
HUSEBYE (1999) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.1999.00147.x · Cited by 258
Early pharmaceutical profiling to predict oral drug absorption: Current status and unmet needs
Bergström, C. A. S., Holm, R., Jørgensen, S. A., Andersson, S. B. E., Artursson, P., Beato, S., Borde, A., Box, K., Brewster, M., Dressman, J., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.10.015 · Cited by 257
Self-citationvon Richter, O., Burk, O., Fromm, M. F., Thon, K. P., Eichelbaum, M., & Kivistö, K. T. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.10.008 · Cited by 255
Nucleation and crystal growth in supersaturated solutions of a model drug
Lindfors, L., Forssén, S., Westergren, J., & Olsson, U. (2008) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2008.05.034 · Cited by 251
Strassburg, C. P., Kneip, S., Topp, J., Obermayer-Straub, P., Barut, A., Tukey, R. H., & Manns, M. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002180200 · Cited by 249
Pang, K. S. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.12.1507 · Cited by 245
Björkman, S. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02225.x · Cited by 244
Jones, H. M., Barton, H. A., Lai, Y., Bi, Y.-A., Kimoto, E., Kempshall, S., Tate, S. C., El-Kattan, A., Houston, J. B., Galetin, A., et al. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.042994 · Cited by 244
Self-citationPAMPA—critical factors for better predictions of absorption
Avdeef, A., Bendels, S., Di, L. I., Faller, B., Kansy, M., Sugano, K., & Yamauchi, Y. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21068 · Cited by 240
Estimating drug solubility in the gastrointestinal tract
Dressman, J. B., Vertzoni, M., Goumas, K., & Reppas, C. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.009 · Cited by 237
Self-citationTukey, R. H., & Strassburg, C. P. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12228-6 · Cited by 237
A Semi-Mechanistic Model to Predict the Effects of Liver Cirrhosis on Drug Clearance
Johnson, T. N., Boussery, K., Rowland-Yeo, K., Tucker, G. T., & Rostami-Hodjegan, A. (2010) · Clinical Pharmacokinetics · doi:10.2165/11318160-000000000-00000 · Cited by 235
Self-citationCompartmental transit and dispersion model analysis of small intestinal transit flow in humans
Yu, L. X., Crison, J. R., & Amidon, G. L. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04592-9 · Cited by 231
Pharmacokinetics and metabolism of nifedipine.
Raemsch, K. D., & Sommer, J. (1983) · Hypertension · doi:10.1161/01.hyp.5.4_pt_2.ii18 · Cited by 228
A Physiological Model for the Estimation of the Fraction Dose Absorbed in Humans
Willmann, S., Schmitt, W., Keldenich, J., Lippert, J., & Dressman, J. B. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030999b · Cited by 219
Self-citationDrugs, Diseases and Altered Gastric Emptying
Nimmo, W. S. (1976) · Clinical Pharmacokinetics · doi:10.2165/00003088-197601030-00002 · Cited by 215
Prediction of adipose tissue: Plasma partition coefficients for structurally unrelated drugs
Poulin, P., Schoenlein, K., & Theil, F. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200104)90:4<436::aid-jps1002>3.0.co;2-p · Cited by 213
Biopharmaceutical classification of poorly soluble drugs with respect to “enabling formulations”
Buckley, S. T., Frank, K. J., Fricker, G., & Brandl, M. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.04.002 · Cited by 213
Solubility and Dissolution Profile Assessment in Drug Discovery
Sugano, K., Okazaki, A., Sugimoto, S., Tavornvipas, S., Omura, A., & Mano, T. (2007) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.22.225 · Cited by 212
Bischoff, K. B., & Dedrick, R. L. (1968) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600570814 · Cited by 211
Nicolaides, E., Symillides, M., Dressman, J. B., & Reppas, C. (2001) · Pharmaceutical Research · doi:10.1023/a:1011071401306 · Cited by 208
Self-citationBerggren, S., Gall, C., Wollnitz, N., Ekelund, M., Karlbom, U., Hoogstraate, J., Schrenk, D., & Lennernäs, H. (2007) · Molecular Pharmaceutics · doi:10.1021/mp0600687 · Cited by 208
Neuhoff, S., Ungell, A.-L., Zamora, I., & Artursson, P. (2003) · Pharmaceutical Research · doi:10.1023/a:1025032511040 · Cited by 206
A comparative study of the gastrointestinal transit of a pellet and tablet formulation
Davis, S. S., Hardy, J. G., Taylor, M. J., Whalley, D. R., & Wilson, C. G. (1984) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(84)90091-7 · Cited by 206
Psachoulias, D., Vertzoni, M., Goumas, K., Kalioras, V., Beato, S., Butler, J., & Reppas, C. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0506-6 · Cited by 205
Eissing, T. (2011) · Frontiers in Physiology · doi:10.3389/fphys.2011.00004 · Cited by 204
Accuracy of calculated pH-dependent aqueous drug solubility
Bergström, C. A. S., Luthman, K., & Artursson, P. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.04.006 · Cited by 197
Zamek-Gliszczynski, M. J., Lee, C. A., Poirier, A., Bentz, J., Chu, X., Ellens, H., Ishikawa, T., Jamei, M., Kalvass, J. C., Nagar, S., et al. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.45 · Cited by 195
Self-citationSolubilization and Wetting Effects of Bile Salts on the Dissolution of Steroids
Bakatselou, V., Oppenheim, R. C., & Dressman, J. B. (1991) · Pharmaceutical Research · doi:10.1023/a:1015877929381 · Cited by 190
Self-citationDoes sex matter? The influence of gender on gastrointestinal physiology and drug delivery
Freire, A. C., Basit, A. W., Choudhary, R., Piong, C. W., & Merchant, H. A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.04.069 · Cited by 190
Wagner, J. G. (1981) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(81)90097-8 · Cited by 183
S. Darwich, A., Neuhoff, S., Jamei, M., & Rostami-Hodjegan, A. (2010) · Current Drug Metabolism · doi:10.2174/138920010794328913 · Cited by 183
Self-citationPhysiologically Based Pharmacokinetic (PBPK) Modeling in Children
Barrett, J. S., Della Casa Alberighi, O., Läer, S., & Meibohm, B. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.64 · Cited by 182
Poulin, P., Jones, R. D. O., Jones, H. M., Gibson, C. R., Rowland, M., Chien, J. Y., Ring, B. J., Adkison, K. K., Ku, M. S., He, H., et al. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22550 · Cited by 174
Sjögren, E., Westergren, J., Grant, I., Hanisch, G., Lindfors, L., Lennernäs, H., Abrahamsson, B., & Tannergren, C. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.05.019 · Cited by 168
Self-citationGaletin, A., & Houston, J. B. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106013 · Cited by 160
Self-citationKalantzi, L., Persson, E., Polentarutti, B., Abrahamsson, B., Goumas, K., Dressman, J. B., & Reppas, C. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0207-8 · Cited by 159
Self-citationShono, Y., Jantratid, E., Janssen, N., Kesisoglou, F., Mao, Y., Vertzoni, M., Reppas, C., & Dressman, J. B. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.05.009 · Cited by 158
Self-citationIto, K., Ogihara, K., Kanamitsu, S.-I., & Itoh, T. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.7.945 · Cited by 151
Gertz, M., Cartwright, C. M., Hobbs, M. J., Kenworthy, K. E., Rowland, M., Houston, J. B., & Galetin, A. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0918-y · Cited by 148
Self-citationExploring the Role of Different Drug Transport Routes in Permeability Screening
Matsson, P., Bergström, C. A. S., Nagahara, N., Tavelin, S., Norinder, U., & Artursson, P. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049711o · Cited by 147
Diakidou, A., Vertzoni, M., Goumas, K., Söderlind, E., Abrahamsson, B., Dressman, J., & Reppas, C. I. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9927-x · Cited by 144
Self-citationWillmann, S., Edginton, A. N., Coboeken, K., Ahr, G., & Lippert, J. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.151 · Cited by 142
Predicting Intestinal Precipitation—A Case Example for a Basic BCS Class II Drug
Carlert, S., Pålsson, A., Hanisch, G., von Corswant, C., Nilsson, C. A. M., Lindfors, L., Lennernäs, H., & Abrahamsson, B. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0213-8 · Cited by 141
Thelen, K., Coboeken, K., Willmann, S., Burghaus, R., Dressman, J. B., & Lippert, J. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22726 · Cited by 139
Self-citationGertz, M., Houston, J. B., & Galetin, A. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.039248 · Cited by 139
Self-citationWeitschies, W., Blume, H. H., & Mönnikes, H. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.07.007 · Cited by 138
Self-citationGu, C., Rao, D. A., Gandhi, R. B., Hilden, J. O. N., & Raghavan, K. S. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20242 · Cited by 136
Shono, Y., Jantratid, E., Kesisoglou, F., Reppas, C. I., & Dressman, J. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.05.009 · Cited by 136
Self-citationIntroduction to computational oral absorption simulation
Sugano, K. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902835506 · Cited by 136
Lumping of Whole-Body Physiologically Based Pharmacokinetic Models
Nestorov, I. A., Aarons, L. J., Arundel, P. A., & Rowland, M. (1998) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1023/a:1023272707390 · Cited by 132
Self-citationCubitt, H. E., Houston, J. B., & Galetin, A. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9823-9 · Cited by 132
Self-citationImpact of the intragastric location of extended release tablets on food interactions
Weitschies, W., Wedemeyer, R., Kosch, O., Fach, K., Nagel, S., Söderlind, E., Trahms, L., Abrahamsson, B., & Mönnikes, H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.08.018 · Cited by 131
Self-citationRodgers, T., Leahy, D. E., & Rowland, M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20323 · Cited by 131
Taupitz, T., Dressman, J., Buchanan, C. M., & Klein, S. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.11.003 · Cited by 130
Self-citationApplications of Physiologically Based Absorption Models in Drug Discovery and Development
Parrott, N. J., & Lavé, T. (2008) · Molecular Pharmaceutics · doi:10.1021/mp8000155 · Cited by 129
Cubitt, H., Houston, J., & Galetin, A. (2011) · Drug Metabolism And Disposition · doi:10.1124/dmd.110.036566 · Cited by 125
Self-citationDrug precipitation–permeation interplay: Supersaturation in an absorptive environment
Bevernage, J., Brouwers, J., Annaert, P., & Augustijns, P. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.07.009 · Cited by 124
Shi, Y., Gao, P., Gong, Y., & Ping, H. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100114a · Cited by 120
Koziolek, M., Garbacz, G., Neumann, M., & Weitschies, W. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300604u · Cited by 119
Self-citationThe effect of L‐leucine on the absorption of levodopa, studied by regional jejunal perfusion in man.
Lennernäs, H., Nilsson, D., Sm, A., Ahrenstedt, Ö., Knutson, L., & Paalzow, L. (1993) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1993.tb05691.x · Cited by 118
Okumu, A., Maso, M. D., & Löbenberg, R. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9642-z · Cited by 116
Variability of migrating motor complex in humans
Dooley, C. P., Lorenzo, C. D., & Valenzuela, J. E. (1992) · Digestive Diseases and Sciences · doi:10.1007/bf01296429 · Cited by 115
Disruptive effect of test meals on interdigestive motor complex in dogs.
Wever, I. D., Eeckhout, C., Vantrappen, G. R., & Hellemans, J. (1978) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1978.235.6.e661 · Cited by 114
Galetin, A., Gertz, M., & Houston, J. B. (2010) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.25.28 · Cited by 113
Self-citationHarwood, M. D., Neuhoff, S., Carlson, G., Warhurst, G., & Rostami‐Hodjegan, A. (2012) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1810 · Cited by 111
Self-citationVarum, F., Merchant, H., & Basit, A. (2010) · International journal of pharmaceutics · doi:10.1016/j.ijpharm.2010.04.046 · Cited by 111
Jones, H. M., Gardner, I. B., Collard, W. T., Stanley, P. J., Oxley, P., Hosea, N. A., Plowchalk, D., Gernhardt, S., Lin, J., Dickins, M., et al. (2011) · Clinical Pharmacokinetics · doi:10.2165/11539680-000000000-00000 · Cited by 110
Kalvass, J. C., & Pollack, G. M. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9135-x · Cited by 109
Kuentz, M., Nick, S., Parrott, N. J., & Röthlisberger, D. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.08.011 · Cited by 108
Juenemann, D., Jantratid, E., Wagner, C., Reppas, C. I., Vertzoni, M., & Dressman, J. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.10.012 · Cited by 108
Self-citationChiu, Y.-Y., Higaki, K., Neudeck, B. L., Barnett, J. L., Welage, L. S., & Amidon, G. L. (2003) · Pharmaceutical Research · doi:10.1023/a:1023481418576 · Cited by 106
Physiologically based pharmacokinetic (PBPK) modelling tools: how to fit with our needs?
Bouzom, F., Ball, K., Perdaems, N., & Walther, B. (2012) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1767 · Cited by 105
Buck, S. S. D., Sinha, V. K., Fenu, L. A., Gilissen, R., Mackie, C. E., & Nijsen, M. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.014027 · Cited by 104
A Physiologic Model for Simulating Gastrointestinal Flow and Drug Absorption in Rats
Willmann, S., Schmitt, W., Keldenich, J., & Dressman, J. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000003373.72652.c0 · Cited by 103
Self-citationSPECIES- AND DISPOSITION MODEL-DEPENDENT METABOLISM OF RALOXIFENE IN GUT AND LIVER: ROLE OF UGT1A10
Jeong, E. J., Liu, Y., Lin, H., & Hu, M. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001883 · Cited by 100
Estimation of effective intestinal membrane permeability considering bile micelle solubilisation
Sugano, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.10.001 · Cited by 99
Ménochet, K., Kenworthy, K. E., Houston, J. B., & Galetin, A. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.187112 · Cited by 99
Self-citationBiopharmaceutics Classification System: Validation and Learnings of an in Vitro Permeability Assay
Thiel-Demby, V. E., Humphreys, J. E., Williams, L. A. S. J., Ellens, H. M., Shah, N., Ayrton, A. D., & Polli, J. W. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800122b · Cited by 98
The transit of dosage forms through the small intestine
Yuen, K.-H. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.045 · Cited by 98
Zhang, X., Quinney, S. K., Gorski, J. C., Jones, D. R., & Hall, S. D. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.026658 · Cited by 97
Gastric juice as a dissolution medium: Surface tension and pH
Efentakis, M., & Dressman, J. (1998) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03189322 · Cited by 96
Self-citationPsachoulias, D., Vertzoni, M., Butler, J., Busby, D. J., Symillides, M., Dressman, J., & Reppas, C. I. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0844-z · Cited by 92
Self-citationSinha, V. K., Snoeys, J., Osselaer, N. V., Peer, A. V., Mackie, C. E., & Heald, D. (2012) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1782 · Cited by 91
Shono, Y., Jantratid, E., & Dressman, J. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.04.005 · Cited by 90
Self-citationMellaerts, R., Mols, R., Kayaert, P., Annaert, P., Humbeeck, J. V., den Mooter, G. V., Martens, J. A., & Augustijns, P. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.01.049 · Cited by 89
Wagner, C., Jantratid, E., Kesisoglou, F., Vertzoni, M., Reppas, C. I., & Dressman, J. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.05.008 · Cited by 88
Self-citationAshiru-Oredope, D. A. I., Patel, R., & Basit, A. W. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9635-y · Cited by 88
Correlation of the Gastric Emptying of Nondisintegrating Tablets with Gastrointestinal Motility
Coupe, A. J., Davis, S. S., Evans, D. F., & Wilding, I. R. (1991) · Pharmaceutical Research · doi:10.1023/a:1015855829864 · Cited by 85
Physiologically Based Pharmacokinetic Model of Mechanism-Based Inhibition of CYP3A by Clarithromycin
Quinney, S. K., Zhang, X., Lucksiri, A., Gorski, J. C., Li, L., & Hall, S. D. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028746 · Cited by 85
Lukáčová, V., Woltosz, W. S., & Bolger, M. B. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9107-2 · Cited by 84
Self-citationKataoka, M., Sugano, K., Mathews, C. D. C., Wong, J. W., Jones, K. L., Masaoka, Y., Sakuma, S., & Yamashita, S. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0623-2 · Cited by 84
Sinko, P. J., & Balimane, P. V. (1998) · Biopharmaceutics & Drug Disposition · Cited by 84
Tucker, T. G. H. A., Milne, A., Fournel‐Gigleux, S., Fenner, K. S., & Coughtrie, M. W. H. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.10.017 · Cited by 81
Yu, L. X., & Amidon, G. L. (1998) · European journal of pharmaceutics and biopharmaceutics · doi:10.1016/s0939-6411(97)00088-x · Cited by 80
Willmann, S., Thelen, K., Becker, C., Dressman, J., & Lippert, J. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.06.003 · Cited by 78
Self-citationHeikkinen, A. T., Baneyx, G., Caruso, A., & Parrott, N. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.06.013 · Cited by 76
Thelen, K., Coboeken, K., Willmann, S., Dressman, J., & Lippert, J. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22825 · Cited by 76
Self-citationTubić-Grozdanis, M., Wagner, D., Spahn-Langguth, H., Bolger, M. B., & Langguth, P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9020-7 · Cited by 70
Self-citationColonic transit of different sized tablets in healthy subjects
Adkin, D. A., Davis, S. S., Sparrow, R. A., & Wilding, I. R. (1993) · Journal of Controlled Release · doi:10.1016/0168-3659(93)90040-c · Cited by 69
Persson, E. M., Nilsson, R. G., Hansson, G. I., Löfgren, L., Libäck, F., Knutson, L., Abrahamsson, B., & Lennernäs, H. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9607-z · Cited by 68
Yamazaki, S., Skaptason, J., Romero, D., Vekich, S., Jones, H. M., Tan, W., Wilner, K. D., & Koudriakova, T. B. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035857 · Cited by 68
Darwich, A. S., Pade, D., Ammori, B. J., Jamei, M., Ashcroft, D. M., & Rostami‐Hodjegan, A. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01538.x · Cited by 67
Self-citationFei, Y., Kostewicz, E. S., Sheu, M., & Dressman, J. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.03.001 · Cited by 66
Self-citationStrougo, A., Eißing, T., Yassen, A., Willmann, S., Danhof, M., & Freijer, J. I. (2012) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-012-9241-9 · Cited by 64
Physiologically based pharmacokinetic models for anticancer drugs
Chen, H.-S. G., & Gross, J. F. (1979) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00254079 · Cited by 64
Nielsen, A. E. (1961) · The Journal of Physical Chemistry · doi:10.1021/j100819a014 · Cited by 64
Fotaki, N., Symillides, M., & Reppas, C. I. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.10.003 · Cited by 61
Meal Composition Effects on the Oral Bioavailability of Indinavir in HIV-Infected Patients
Carver, P. L., Fleisher, D., Zhou, S. Y., Kaul, D. R., Kazanjian, P. H., & Li, C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018880726035 · Cited by 59
Kambayashi, A., Blume, H. H., & Dressman, J. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.09.009 · Cited by 58
Self-citationNeuhoff, S., Yeo, K. R., Barter, Z. E., Jamei, M., Turner, D. B., & Rostami‐Hodjegan, A. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23607 · Cited by 57
Self-citationModels to Predict Unbound Intracellular Drug Concentrations in the Presence of Transporters
Korzekwa, K., Nagar, S., Tucker, J., Weiskircher-Hildebrandt, E. A., Bhoopathy, S., & Hidalgo, I. J. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.044289 · Cited by 56
Berezhkovskiy, L. M. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10539 · Cited by 55
Predictive models for oral drug absorption: from in silico methods to integrated dynamical models
Dokoumetzidis, A., Kalantzi, L., & Fotaki, N. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.3.4.491 · Cited by 55
Willmann, S., Edginton, A. N., & Dressman, J. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9247-y · Cited by 52
Self-citationIn SilicoModeling for the Nonlinear Absorption Kinetics of UK-343,664: A P-gp and CYP3A4 Substrate
Abuasal, B., Bolger, M. B., Walker, D. K., & Kaddoumi, A. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200275j · Cited by 52
Self-citationCrison, J. R., Timmins, P., Keung, A., Upreti, V. V., Boulton, D. W., & Scheer, B. J. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23063 · Cited by 45
Arnold, Y. E., Imanidis, G., & Kuentz, M. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01228.x · Cited by 44
Patel, N. K., Polak, S., Jamei, M., Rostami‐Hodjegan, A., & Turner, D. B. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.09.006 · Cited by 44
Self-citationKnutson, T. W., Fridblom, P., Ahlstrom, H., Magnusson, Å., Tannergren, C., & Lennernäs, H. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800145r · Cited by 39
Self-citationEißing, T., Lippert, J., & Willmann, S. (2012) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256429 · Cited by 37
Heikkinen, A. T., Friedlein, A., Lamerz, J., Jakob, P., Cutler, P., Fowler, S. M., Williamson, T., Tolando, R., Lavé, T., & Parrott, N. J. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0707-7 · Cited by 37
Evidence for Site-Specific Absorption of a Novel ACE Inhibitor
Grass, G. M., & Morehead, W. T. (1989) · Pharmaceutical Research · doi:10.1023/a:1015919413103 · Cited by 36
Gender Differences in Drug Bioequivalence: Time to Rethink Practices
Koren, G., Nordeng, H., & MacLeod, S. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.233 · Cited by 35
Van den Bergh, A., Sinha, V., Gilissen, R., Straetemans, R., Wuyts, K., Morrison, D., Bijnens, L., & Mackie, C. (2011) · Clinical Pharmacokinetics · doi:10.2165/11587230-000000000-00000 · Cited by 33
Bergstrand, M., Söderlind, E., Weitschies, W., & Karlsson, M. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.43 · Cited by 33
Self-citationQuinney, S. K., Galinsky, R. E., Jiyamapa‐Serna, V. A., Chen, Y., Hamman, M. A., Hall, S. D., & Kimura, R. E. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.020644 · Cited by 30
Pang, K. S., & Chow, E. C. Y. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.045872 · Cited by 29
Willmann, S., Edginton, A. N., Kleine-Besten, M., Jantratid, E., Thelen, K., & Dressman, J. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.07.0008 · Cited by 28
Self-citationThelen, K., Jantratid, E., Dressman, J., Lippert, J., & Willmann, S. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22026 · Cited by 28
Self-citationEißing, T., Lippert, J., & Willmann, S. (2012) · PubMed · doi:10.2165/11597930-000000000-00000 · Cited by 27
Nocturnal scintigraphic imaging to investigate the gastrointestinal transit of dosage forms
Coupe, A. J., Davis, S. S., Evans, D. F., & Wilding, I. R. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90161-j · Cited by 26
Gut Transit in Celiac Disease: Delay of Small Bowel Transit and Acceleration after Dietary Treatment
Sadik, R., Abrahamsson, H., Kilander, A. F., & Stotzer, P. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40406.x · Cited by 26
The effect of sleep on the gastrointestinal transit of pharmaceutical dosage forms
Coupe, A. J., Davis, S. S., Evans, D. F., & Wilding, I. R. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90356-7 · Cited by 26
Effect of dosing time on the total intestinal transit time of non-disintegrating systems
Sathyan, G., Hwang, S. S., & Gupta, S. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00472-5 · Cited by 25
Bungay, P. J., Tweedy, S., Howe, D. C., Gibson, K. R., Jones, H. M., & Mount, N. M. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.037234 · Cited by 23
Cited by
The Role of Reactive Oxygen Species in Arsenic Toxicity
Hu, Y., Li, J., Lou, B., Wu, R., Wang, G., Lu, C., Wang, H., Pi, J., & Xu, Y. (2020) · Biomolecules · doi:10.3390/biom10020240 · Cited by 413
Berry, D. J., & Steed, J. W. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.03.003 · Cited by 406
Workgroup, E. M., Marshall, S., Burghaus, R., Cosson, V, Cheung, S., Chenel, M., DellaPasqua, O., Frey, N., Hamrén, B., Harnisch, L., et al. (2016) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12049 · Cited by 373
Boyd, B. J., Bergström, C. A. S., Vinarov, Z., Kuentz, M., Brouwers, J., Augustijns, P., Brandl, M., Bernkop-Schnürch, A., Shrestha, N., Préat, V., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.104967 · Cited by 367
Food, gastrointestinal pH, and models of oral drug absorption
Abuhelwa, A. Y., Williams, D. B., Upton, R. N., & Foster, D. J. R. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.11.034 · Cited by 349
Metadata
- Authors
- Kostewicz, E. S., Aarons, L., Bergstrand, M., Bolger, M. B., Galetin, A., Hatley, O., Jamei, M., Lloyd, R., Pepin, X., Rostami-Hodjegan, A., Sjögren, E., Tannergren, C., Turner, D. B., Wagner, C., Weitschies, W., & Dressman, J.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2014-06
- Volume
- 57
- Pages
- 300-321
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2115848859
- Cited by
- 315
- References
- 209
- FWCI
- 13.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.